BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9454621)

  • 21. Intrathecal magnesium sulfate administration at the time of experimental ischemia improves neurological functioning by reducing acute and delayed loss of motor neurons in the spinal cord.
    Jellish WS; Zhang X; Langen KE; Spector MS; Scalfani MT; White FA
    Anesthesiology; 2008 Jan; 108(1):78-86. PubMed ID: 18156885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the neuroprotective effects of the acetylcholinesterase inhibitor huperzine A in an experimental spinal cord trauma model.
    Antar V; Baran O; Yuceli S; Erdogan H; Altintas O; Baran GE; Tasdemiroglu E
    J Neurosurg Sci; 2018 Apr; 62(2):128-139. PubMed ID: 26472141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats.
    Puurunen K; Jolkkonen J; Sirviö J; Haapalinna A; Sivenius J
    Exp Neurol; 2001 Feb; 167(2):348-55. PubMed ID: 11161623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor 1 prevents neuronal cell death and paraplegia in the rabbit model of spinal cord ischemia.
    Nakao Y; Otani H; Yamamura T; Hattori R; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jul; 122(1):136-43. PubMed ID: 11436046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sevoflurane preconditioning induces rapid ischemic tolerance against spinal cord ischemia/reperfusion through activation of extracellular signal-regulated kinase in rabbits.
    Ding Q; Wang Q; Deng J; Gu Q; Hu S; Li Y; Su B; Zeng Y; Xiong L
    Anesth Analg; 2009 Oct; 109(4):1263-72. PubMed ID: 19762756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons.
    Iwasaki Y; Ikeda K; Shiojima T; Kobayashi T; Tagaya N; Kinoshita M
    J Neurol Sci; 1994 Aug; 125(1):11-3. PubMed ID: 7964880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter-relationships between spinal cord blood flow, neuronal death and neurological function in rabbit spinal cord ischemia.
    Weir CJ; Zivin JA; Lyden PD
    Brain Res; 2002 Aug; 946(1):43-51. PubMed ID: 12133593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inductions of 3-L-nitrotyrosine in motor neurons after transient spinal cord ischemia in rabbits.
    Sakurai M; Fukuyama N; Takizawa S; Abe K; Hayashi T; Shinohara Y; Nakazawa H; Tabayashi K
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1233-8. PubMed ID: 9809512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons.
    Engberg G; Elebring T; Nissbrandt H
    J Pharmacol Exp Ther; 1991 Nov; 259(2):841-7. PubMed ID: 1658311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild hypothermia protects against irreversible damage during prolonged spinal cord ischemia.
    Kwun BD; Vacanti FX
    J Surg Res; 1995 Dec; 59(6):780-2. PubMed ID: 8538181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
    Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cilostazol on oxidative stress, systemic cytokine release, and spinal cord injury in a rat model of transient aortic occlusion.
    Kurtoglu T; Basoglu H; Ozkisacik EA; Cetin NK; Tataroglu C; Yenisey C; Discigil B
    Ann Vasc Surg; 2014 Feb; 28(2):479-88. PubMed ID: 24485778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the dose-dependent neuroprotective effects of agmatine in experimental spinal cord injury: a prospective randomized and placebo-control trial.
    Kotil K; Kuscuoglu U; Kirali M; Uzun H; Akçetin M; Bilge T
    J Neurosurg Spine; 2006 May; 4(5):392-9. PubMed ID: 16703907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible role of antioxidative capacity of (-)-epigallocatechin-3-gallate treatment in morphological and neurobehavioral recovery after sciatic nerve crush injury.
    Renno WM; Benov L; Khan KM
    J Neurosurg Spine; 2017 Nov; 27(5):593-613. PubMed ID: 28777065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of cyclosporin-A on functional outcome and axonal regrowth following spinal cord injury in adult rats.
    Roozbehi A; Joghataie MT; Mehdizadeh M; Mirzaei A; Delaviz H
    Acta Med Iran; 2012; 50(4):226-32. PubMed ID: 22592571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of heparin on neuroprotection against spinal cord ischemia and reperfusion in rats.
    Korkmaz K; Gedik HS; Budak AB; Erdem H; Lafci G; Karakilic E; Nacar OA; Yildirim L; Ankarali H
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):522-30. PubMed ID: 23467953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The administration of neurocytoprotectors in a rat model of experimental spinal cord ischemia].
    Ponomarev GV; Shmonin AA; Shumeeva AG; Aliev KT; Vlasov TD; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):42-46. PubMed ID: 28745670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation of systemic blood pressure during spinal cord ischemia to prevent postoperative paraplegia after aortic surgery in a rabbit model.
    Izumi S; Okada K; Hasegawa T; Omura A; Munakata H; Matsumori M; Okita Y
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1261-8. PubMed ID: 19910005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecally injected granulocyte colony-stimulating factor produced neuroprotective effects in spinal cord ischemia via the mitogen-activated protein kinase and Akt pathways.
    Chen WF; Jean YH; Sung CS; Wu GJ; Huang SY; Ho JT; Su TM; Wen ZH
    Neuroscience; 2008 Apr; 153(1):31-43. PubMed ID: 18358629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl.
    Boyce S; Webb JK; Carlson E; Rupniak NM; Hill RG; Martin JE
    Exp Neurol; 1999 Jan; 155(1):49-58. PubMed ID: 9918704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.